Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome

Objective The gut-derived hormone, ghrelin, improves cardiac function in healthy individuals and patients with chronic heart failure. The aim of this study was to investigate whether the major isoforms of the hormone, acylated and desacyl ghrelin, are related to inappropriate left ventricular mass in patients with the metabolic syndrome (MetS). Methods and results Plasma concentrations of ghrelin forms were measured in 180 white participants (65 normal weight, 60 obese without MetS and 55 obese with MetS; 56% men). MetS was defined according to Adult Treatment Panel III criteria. The presence of left ventricular hypertrophy (LVH) was diagnosed by sex-specific left ventricular mass/height2.7 cut-off values (>49.2 g/m2.7 for men and >46.7 g/m2.7 for women). Circulating concentrations of acylated ghrelin were increased in obesity and MetS, whereas desacyl ghrelin levels were decreased. Compared with participants in the lowest tertiles, the age-adjusted and sex-adjusted odds of having MetS were lower in the highest category of desacyl ghrelin (odds ratio 0.1, 95% confidence interval 0.1–0.4, P < 0.001). The prevalence of LVH was increased in the highest tertile of acylated ghrelin (odds ratio 3.4, 95% confidence interval 1.7–5.6, P < 0.05). Plasma acylated ghrelin was increased (P < 0.05) in patients with MetS exhibiting LVH compared with those with appropriate left ventricular mass, whereas plasma desacyl ghrelin was not changed (P = 0.490). Conclusion Acylated ghrelin was positively associated with SBP and left ventricular mass indices, even after correction for BMI. These results suggest that the increased acylated ghrelin concentrations may represent a compensatory mechanism to overcome the development of hypertension and LVH in patients with MetS.

[1]  G. Frühbeck,et al.  Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes , 2009, International Journal of Obesity.

[2]  Suna Aydin,et al.  Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy and preeclamptic pregnant women , 2008, Journal of Physiology and Biochemistry.

[3]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[4]  T. Tokudome,et al.  Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. , 2008, Endocrinology.

[5]  C. Diéguez,et al.  Introducing GOAT: a target for obesity and anti-diabetic drugs? , 2008, Trends in pharmacological sciences.

[6]  N. Grishin,et al.  Identification of the Acyltransferase that Octanoylates Ghrelin, an Appetite-Stimulating Peptide Hormone , 2008, Cell.

[7]  G. Frühbeck,et al.  Expression of caveolin‐1 in human adipose tissue is upregulated in obesity and obesity‐associated type 2 diabetes mellitus and related to inflammation , 2007, Clinical endocrinology.

[8]  T. Tokudome,et al.  Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. , 2008, American journal of physiology. Heart and circulatory physiology.

[9]  N. Møller,et al.  Cardiovascular Effects of Intravenous Ghrelin Infusion in Healthy Young Men Study Subjects , 2022 .

[10]  B. Ciocchi,et al.  Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  G. Frühbeck,et al.  Influence of Waist Circumference on the Metabolic Risk Associated with Impaired Fasting Glucose: Effect of Weight Loss after Gastric Bypass , 2007, Obesity surgery.

[12]  H. Issever,et al.  Circulating ghrelin levels in obese women: a possible association with hypertension , 2007, Scandinavian journal of clinical and laboratory investigation.

[13]  K. Cianflone,et al.  Association of acylated and nonacylated ghrelin with insulin sensitivity in overweight and obese postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  Xiaorong Zhu,et al.  On the Processing of Proghrelin to Ghrelin* , 2006, Journal of Biological Chemistry.

[15]  P. Pfluger,et al.  Ghrelin action in the brain controls adipocyte metabolism. , 2006, The Journal of clinical investigation.

[16]  J. Erdmann,et al.  Association of the Ghrelin Receptor Gene Region With Left Ventricular Hypertrophy in the General Population: Results of the MONICA/KORA Augsburg Echocardiographic Substudy , 2006, Hypertension.

[17]  E. Barrett-Connor,et al.  Ghrelin and the metabolic syndrome in older adults. , 2005, The Journal of clinical endocrinology and metabolism.

[18]  D. Lauro,et al.  Ghrelin Improves Endothelial Function in Patients With Metabolic Syndrome , 2005, Circulation.

[19]  E. Ghigo,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):1055–1060 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2004-1069 Ghrelin Stimulates, Whereas Des-Octanoyl Ghrelin Inhibits, Glucose Output by Pri , 2022 .

[20]  H. Kauma,et al.  The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes , 2005, Diabetologia.

[21]  W. Shimizu,et al.  Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart Failure , 2004, Circulation.

[22]  R. Piñeiro,et al.  Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. , 2004, Cardiovascular research.

[23]  M. Iida,et al.  Ghrelin Acts at the Nucleus of the Solitary Tract to Decrease Arterial Pressure in Rats , 2004, Hypertension.

[24]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[25]  D. Malan,et al.  Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT , 2002, The Journal of cell biology.

[26]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[27]  A. Davenport,et al.  G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors. , 2002, Clinical science.

[28]  C. Sempoux,et al.  Expression of cholecystokinin in the duodenum of patients with coeliac disease: respective role of atrophy and lymphocytic infiltration. , 2002, Clinical science.

[29]  T. Kawarabayashi,et al.  Alteration of Plasma Ghrelin Levels Associated With the Blood Pressure in Pregnancy , 2002, Hypertension.

[30]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[31]  W. Shimizu,et al.  Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. , 2001, The Journal of clinical endocrinology and metabolism.

[32]  R. Batterham,et al.  Ghrelin causes hyperphagia and obesity in rats. , 2001, Diabetes.

[33]  W. Shimizu,et al.  Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart Failure , 2001, Circulation.

[34]  K. Kangawa,et al.  Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  E. Ravussin,et al.  Circulating ghrelin levels are decreased in human obesity. , 2001, Diabetes.

[36]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[37]  K. Kangawa,et al.  Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. , 2000, Biochemical and biophysical research communications.

[38]  S. Bloom,et al.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. , 2000, Endocrinology.

[39]  M. Tschöp,et al.  Ghrelin induces adiposity in rodents , 2000, Nature.

[40]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[41]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[42]  R. Devereux,et al.  Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[43]  D. Mirvis,et al.  Left ventricular hypertrophy: effect on survival. , 1993, Journal of the American College of Cardiology.

[44]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[45]  D. Levy,et al.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[46]  J. Laragh,et al.  Standardization of M-mode echocardiographic left ventricular anatomic measurements. , 1984, Journal of the American College of Cardiology.

[47]  J. Laragh,et al.  Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension. , 1983, The American journal of cardiology.